We are a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies.
| Website | http://arcellx.com |
| Revenue | $107.9 million |
| Employees | 221 (186 on RocketReach) |
| Founded | 2015 |
| Address | 800 Bridge Pkwy, Redwood City, California 94065, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+42 more
(view full list)
|
| Industry | Biotechnology Research, Biopharma, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| Keywords | Cell Therapy, Innovative Therapies, Immunotherapy, Biotechnology, New Treatments, Clinical Stage, Cancer Treatment, Oncology, Pharmaceutical, Biopharma, Drug Development, T Cell Therapy, Cell Engineering, Gene Therapy, Regenerative Medicine, Precision Medicine, Clinical Trials, Therapeutics, Biologics |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, Novartis, Gilead Sciences, AbbVie, Regeneron, Merck AH +42 more (view full list) |
Looking for a particular Arcellx employee's phone or email?
The Arcellx annual revenue was $107.9 million in 2026.
Rami Elghandour is the Chairman and Chief Executive Officer of Arcellx.
186 people are employed at Arcellx.
Arcellx is based in Redwood City, California.